The extended review for Elinzanetant is supported by data from the Phase III OASIS 1, 2, and 3 trials, which supported the drug’s efficacy in the treatment of moderate to severe vasomotor symptoms due to menopause.

After losing 3,500 employees in April—19% of its workforce due to congressional budget cuts—the FDA is now struggling to meet drug approval deadlines. | After losing 3,500 employees in April—19% of its workforce due to congressional budget cuts—the FDA is now struggling to meet drug approval deadlines.

The U.S. Food and Drug Administration has extended its review of Bayer's experimental menopause relief drug, the German company said on Friday. The non-hormonal treatment, elinzanetant, is being reviewed for relieving moderate to severe vasomotor symptoms,

Bayer says this is just the beginning, with 240,000 additional credits in the pipeline and expected to be issued as carbon credits later this year. A regenerative tonne is equal to approximately ...

Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside. Learn why BAYRY stock is a Buy.

There was a ceiling,” he said. "I saw the chance to do something different—something I could shape from scratch.”

Bayer’s history is on its website, which acknowledges IG Farben’s production of synthetic rubbers that were vital to the war effort. It accepts that the company depended on thousands of slave ...

Together, Bayer and Corteva now control approximately 70% of the corn and soybean seed market in the U.S., a significant increase from around 40% two decades ago, according to USDA data.

An independent playing philosophy, full-time coaches and the long-term objective of the first-team squad: With a new structure in the junior women's section, Bayer 04 are aiming to achieve recognition as an official DFB talent support centre in Women's football in the 2025/26 season.